For Professionals & Researchers
Clinical tools, research frameworks, and community for advancing the TSD paradigm
The TSD Framework
Traumatic Stress Disorder (TSD) proposes a paradigm shift: what we currently diagnose as PTSD, CPTSD, and Cluster B Personality Disorders are manifestations of a single underlying phenomenon—present-tense survival governance.
Core Insight
The nervous system doesn't know the threat ended. A Survival Self seized executive control during trauma, exiling the Core Self. Treatment is the process of restoring sovereignty.
Four Patterns
- • Abandoned Monarchy (Borderline)
- • Fortress City-State (Narcissistic)
- • Predatory Fiefdom (Antisocial)
- • Theatrical Court (Histrionic)
Four Diagnostic Criteria
Diagnostic Code: 309.89 (F43.9) • Staging: PreTSD → TSD (Active) → PostTSD (Integration) • Treatment: Somatic, parts-based, sovereignty-focused
The White Paper
Complete TSD framework: diagnostic criteria, staging, neurobiological map, and treatment protocols
Clinical Quick Start
5-minute guide, 3 key assessment questions, and the Provisional Government Protocol
Deep Dive: The Model
Internal Kingdom framework, Survival Constitutions, neurobiological evidence, and staging
Join the Community
Connect with clinicians, researchers, and advocates building the TSD paradigm
Why TSD Matters: The $280B Case
F31.9: Bipolar Disorder, Unspecified
This single "unspecified" diagnosis code costs the U.S. $280 billion annually. It represents diagnostic uncertainty—we treat symptoms without understanding mechanism.
TSD Offers Specificity
Many "bipolar" presentations may be TSD with Oscillating Survival States—not endogenous mood disorder, but trauma-based nervous system dysregulation.
Clinical Mapping
- Manic: Hyper-arousal survival state (fight/flight energy)
- Depressive: Hypo-arousal shutdown (freeze/collapse)
- Rapid Cycling: Unstable Survival Self governance
- Mixed Episodes: "Wired but frozen" - The Unfinished Gesture
- "I'm not myself": Altered Sovereignty - Core Self exiled
If 20% of F31.9 is TSD: $56B in misdirected treatment. Patients could achieve PostTSD integration instead of lifelong symptom management.
Clinical Question: Before defaulting to bipolar diagnosis, ask: "What is the nervous system trying to survive?"
Research & Validation Opportunities
We're actively seeking research partners to validate the TSD framework. This is an open collaboration—not proprietary. If you're a researcher, academic institution, or health system interested in studying TSD, let's partner.
Priority Research Questions
- • What % of F31.9 patients have undiagnosed trauma histories?
- • Do F31.9 patients respond better to SE+IFS vs. standard bipolar treatment?
- • Can we predict which "bipolar" patients are actually TSD using somatic/trauma assessments?
- • What is the long-term outcome of TSD treatment vs. traditional management?
- • What is the economic impact of reclassifying trauma-based "bipolar" as TSD?
What We Provide
- • Complete diagnostic framework (DSM proposal format)
- • Assessment tools (AI-powered bipolar-TSD screener)
- • Data collection infrastructure (secure, HIPAA-compliant)
- • Community of potential study participants
- • Funding assistance (help with grant writing)
Proposed Study Design (RCT)
Population: Adults diagnosed F31.9 with trauma history + poor medication response
Intervention Group: TSD treatment (SE + IFS + neurofeedback) + pharmacotherapy as bridge
Control Group: Standard bipolar care (mood stabilizers + supportive therapy)
Primary Outcome: Sustained remission at 12 months
Secondary Outcomes: Quality of life, medication burden, cost per patient, PostTSD achievement
Implementation Roadmap for Health Systems
If you're a hospital administrator, clinic director, or health system leader interested in adopting the TSD framework, here's how to implement it within your organization.
Pilot Phase (Months 1-3)
- • Train 3-5 clinicians in TSD assessment (use our toolkit)
- • Screen 50-100 "treatment-resistant" or F31.9 patients
- • Track: Time to assessment, patient satisfaction, preliminary outcomes
- • Cost: Minimal (training materials provided free)
Scale Phase (Months 4-12)
- • Train all trauma/mood disorder clinicians (20-50 people)
- • Integrate TSD screening into standard intake
- • Partner with us on outcome tracking
- • Expected: 20-30% of "bipolar" patients reclassified, better outcomes
Optimization Phase (Year 2+)
- • Publish case series or pilot study results
- • Adjust billing/documentation workflows
- • Calculate cost savings (reduced medications, fewer hospitalizations)
- • Share learnings with broader TSD community
ROI Projection: If 20% of F31.9 patients are TSD and treatment costs drop from $250K+ lifetime to $50K (trauma-focused, 18-24 months), health systems save $200K per correctly diagnosed patient.
Media Kit & Press Resources
One-Sentence Summary
"Traumatic Stress Disorder (TSD) is a proposed diagnostic framework that reclassifies many 'bipolar disorder' and 'personality disorder' diagnoses as trauma-based survival responses, potentially redirecting $280 billion in annual U.S. healthcare spending."
Key Statistics
- • $280B/year spent on F31.9 (Bipolar, Unspecified)
- • 40-60% don't achieve sustained remission
- • 20-60% of F31.9 may be TSD (trauma-based)
- • $200K+ potential savings per correctly diagnosed patient
Story Angles for Journalists
- • Economic: "The $280 billion diagnostic error"
- • Clinical: "What if 'bipolar' is actually trauma?"
- • Patient: "Treatment-resistant? Or misdiagnosed?"
- • System: "Psychiatry's $280B blind spot"
- • Tech: "AI-powered trauma assessment challenges DSM"
Target Publications
- • Psychology Today, Medscape, STAT News
- • The Atlantic, New York Times (Health section)
- • Psychiatric Times, JAMA Psychiatry
- • TechCrunch (AI health angle)
Downloadable Assets
Press inquiries or collaboration opportunities?
Contact via CommunityComing soon: LiveKit Town Hall Chambers, Clinical Council, Real-time Case Consultation
Building the infrastructure for live collaboration